Oxalate homeostasis is maintained in part by a diverse consortium of bacteria in the gut that includes oxalate-degrading bacteria and other functional groups that benefit indirectly from oxalate exposure. Individuals with an active episode of urinary stone disease (USD) harbor a reduced diversity of bacteria from this oxalate-degrading microbial network (ODMN). The objective of this study was to elucidate the metabolic function of the ODMN and its relevance to USD.
INTRODUCTION AND OBJECTIVES:
Oxalate homeostasis is maintained in part by a diverse consortium of bacteria in the gut that includes oxalate-degrading bacteria and other functional groups that benefit indirectly from oxalate exposure. Individuals with an active episode of urinary stone disease (USD) harbor a reduced diversity of bacteria from this oxalate-degrading microbial network (ODMN). The objective of this study was to elucidate the metabolic function of the ODMN and its relevance to USD.
METHODS: The metabolic potential of the ODMN was determined for the gut microbiota of Neotoma albigula, a wild rodent that consumes a high oxalate diet in the wild, through comparative shotgun metagenomics. The resulting metabolic structure of the ODMN was validated through both in vitro and in vivo systems that involved the substrates and bacteria hypothesized to be a part of the ODMN. Finally, the relevance of the ODMN function to USD was determined by comparing the urinary metabolic profile of USD patients to individuals with no history of USD.
RESULTS: Metagenomics produced a three-step model of the ODMN: 1) Oxalate metabolism; 2) Acetogenesis, methanogenesis, and sulfate-reduction; and 3) Gluconeogenesis, fatty acid synthesis, and the citric acid cycle. Addition of substrates or bacteria hypothesized to be a part of the ODMN in vitro resulted in a 7-fold or 2.5-fold increase oxalate metabolism than if they were omitted, respectively. In mice inoculated by the N. albigula microbiota, 85% of fecal metabolites that were more abundant after exposure to dietary oxalate could be attributed to the 3rd step of the hypothesized ODMN, compared to 50% for mice with their native microbiota. In clinical urine samples, of the metabolites that differentiated healthy individuals from those with USD, 88% mapped to the 3rd step of the hypothesized ODMN metabolic network.
CONCLUSIONS: Animal and clinical studies reveal that oxalate metabolism is associated with a diverse consortium of bacteria and that individuals with USD harbor a reduced consortium of bacteria associated with oxalate metabolism compared to individuals with no history of USD. Results of the current study elucidates the extended function of the ODMN, validates the structure through in vitro and in vivo models, and shows that the urinary metabolic profile of individuals with USD reflects reduced activity of the ODMN, corroborating microbial metagenomic results.
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INTRODUCTION AND OBJECTIVES:
We have demonstrated the control of urinary stone formation using macrophages (Mf) in basic research. The purpose of this study is to establish a method for analysis of crystal phagocytosis by human induced pluripotent stem cell (iPSC)-derived Mfs in order to construct a drug discovery screening model. METHODS: After transferring blood cell-derived human iPSCs (610 B1) to a non-feeder culture, primitive linear-like cells were induced with BMP4; vascular stem cell-like cells were induced with VEGF, basic FGF, and SCF; hematopoietic cells were prepared using hematopoietic cytokines (SCF/FL3/IL-3/TPO/M-CSF); and specific differentiation of a monocyte lineage was performed using Flt-3 ligand, GM-CSF, and M-CSF. Thereafter, the CD14þ monocyte lineage specific cell fraction was separated from the floating cells and differentiated into Mfs using M-CSF. The iPSC-derived Mfs were divided into group A (adhering to culture dish) and group F (floating in culture media), and the fluorescent Alexa-Fluor 488-attached calcium oxalate monohydrate (f-COM) crystals were exposed to both groups for 24 hours. Both groups were then fixed with 4% PFA, the cytoplasm and nucleus were stained with phalloidin and DAPI, respectively, and the number of f-COM crystals phagocytosed by iPSC-derived Mfs was measured with InCell Analyzer 6000.
RESULTS: The iPSCs formed dense cell aggregates immediately after the initiation of differentiation, and CD14þ monocyte lineage specific cells were well separated. One week after administration of M-CSF, the iPSC-derived Mfs were able to phagocytose f-COM crystals in both A and F groups. There was no significant difference in the number of cells between the 2 groups, but the A group showed significantly larger area (1.28 times, p <0.05), higher fluorescence intensity (1.33 times, p <0.05), and higher number (1.24 times, p <0.05) of f-COM crystals per cell than the F group.
CONCLUSIONS: We have established a completely new method to measure the rate of phagocytosis of calcium oxalate crystals by Mfs differentiated from human iPSCs derived from blood cells. Cells derived from iPSCs were thought to have higher phagocytic activity towards crystals than floating cells. The basic mechanisms of ureteral stent morbidity is not well understood. Reducing the inflammatory process associated with a stent may decrease symptoms related to ureteral stents. We evaluated the acute and sub-acute effects of a ureteral stent coated with HCQþNAC (hydroxychroloquineþN
